These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

733 related articles for article (PubMed ID: 25531448)

  • 1. PARP inhibition restores extrinsic apoptotic sensitivity in glioblastoma.
    Karpel-Massler G; Pareja F; Aimé P; Shu C; Chau L; Westhoff MA; Halatsch ME; Crary JF; Canoll P; Siegelin MD
    PLoS One; 2014; 9(12):e114583. PubMed ID: 25531448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells.
    Min A; Im SA; Kim DK; Song SH; Kim HJ; Lee KH; Kim TY; Han SW; Oh DY; Kim TY; O'Connor MJ; Bang YJ
    Breast Cancer Res; 2015 Mar; 17():33. PubMed ID: 25888415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation.
    Kim EH; Yoon MJ; Kim SU; Kwon TK; Sohn S; Choi KS
    Cancer Res; 2008 Jan; 68(1):266-75. PubMed ID: 18172319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tanshinone IIA Facilitates TRAIL Sensitization by Up-regulating DR5 through the ROS-JNK-CHOP Signaling Axis in Human Ovarian Carcinoma Cell Lines.
    Chang CC; Kuan CP; Lin JY; Lai JS; Ho TF
    Chem Res Toxicol; 2015 Aug; 28(8):1574-83. PubMed ID: 26203587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vernodalol enhances TRAIL-induced apoptosis in diffuse large B-cell lymphoma cells.
    Wu W; Yang Y; Deng G; Ma L; Wei G; Zheng G; Han X; He D; Zhao Y; He J; Cai Z; Yu R
    Mol Carcinog; 2017 Oct; 56(10):2190-2199. PubMed ID: 28467689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quercetin enhances apoptotic effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in ovarian cancer cells through reactive oxygen species (ROS) mediated CCAAT enhancer-binding protein homologous protein (CHOP)-death receptor 5 pathway.
    Yi L; Zongyuan Y; Cheng G; Lingyun Z; Guilian Y; Wei G
    Cancer Sci; 2014 May; 105(5):520-7. PubMed ID: 24612139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thioridazine Sensitizes Apoptotic Effect of TRAIL in Human Lung Cancer PC9 Cells Through ER Stress Mediated Up-regulation of DR5].
    Li J; Wang Y; Liu L; Yuan Y; Bao Y
    Zhongguo Fei Ai Za Zhi; 2017 Feb; 20(2):80-87. PubMed ID: 28228218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand.
    Yasuda T; Yoshida T; Goda AE; Horinaka M; Yano K; Shiraishi T; Wakada M; Mizutani Y; Miki T; Sakai T
    Mol Cancer Res; 2008 Dec; 6(12):1852-60. PubMed ID: 19074830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamine deprivation sensitizes human breast cancer MDA-MB-231 cells to TRIAL-mediated apoptosis.
    Dilshara MG; Jeong JW; Prasad Tharanga Jayasooriya RG; Neelaka Molagoda IM; Lee S; Park SR; Choi YH; Kim GY
    Biochem Biophys Res Commun; 2017 Apr; 485(2):440-445. PubMed ID: 28202415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celastrol enhances TRAIL-induced apoptosis in human glioblastoma via the death receptor pathway.
    Cha Z; Cheng J; Xiang H; Qin J; He Y; Peng Z; Jia J; Yu H
    Cancer Chemother Pharmacol; 2019 Oct; 84(4):719-728. PubMed ID: 31281953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rad51 Degradation: Role in Oncolytic Virus-Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma.
    Ning J; Wakimoto H; Peters C; Martuza RL; Rabkin SD
    J Natl Cancer Inst; 2017 Mar; 109(3):1-13. PubMed ID: 28376211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verrucarin A sensitizes TRAIL-induced apoptosis via the upregulation of DR5 in an eIF2α/CHOP-dependent manner.
    Moon DO; Asami Y; Long H; Jang JH; Bae EY; Kim BY; Choi YH; Kang CH; Ahn JS; Kim GY
    Toxicol In Vitro; 2013 Feb; 27(1):257-63. PubMed ID: 22982206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(ADP-ribose) polymerase inhibitors sensitize cancer cells to death receptor-mediated apoptosis by enhancing death receptor expression.
    Meng XW; Koh BD; Zhang JS; Flatten KS; Schneider PA; Billadeau DD; Hess AD; Smith BD; Karp JE; Kaufmann SH
    J Biol Chem; 2014 Jul; 289(30):20543-58. PubMed ID: 24895135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanism.
    Ortiz-Ferrón G; Yerbes R; Eramo A; López-Pérez AI; De Maria R; López-Rivas A
    Cell Res; 2008 Jun; 18(6):664-76. PubMed ID: 18458681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-targeting poly(ADP-ribose) polymerase (PARP) and histone deacetylase (HDAC) in triple-negative breast cancer: Higher synergism in BRCA mutated cells.
    Marijon H; Lee DH; Ding L; Sun H; Gery S; de Gramont A; Koeffler HP
    Biomed Pharmacother; 2018 Mar; 99():543-551. PubMed ID: 29902865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PARP-1 regulates resistance of pancreatic cancer to TRAIL therapy.
    Yuan K; Sun Y; Zhou T; McDonald J; Chen Y
    Clin Cancer Res; 2013 Sep; 19(17):4750-9. PubMed ID: 23833311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of euchromatin histone-lysine N-methyltransferase 2 sensitizes breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through reactive oxygen species-mediated activating transcription factor 4-C/EBP homologous protein-death receptor 5 pathway activation.
    Kim SY; Hong M; Heo SH; Park S; Kwon TK; Sung YH; Oh Y; Lee S; Yi GS; Kim I
    Mol Carcinog; 2018 Nov; 57(11):1492-1506. PubMed ID: 29964331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Aminobenzamide protects primary human keratinocytes from UV-induced cell death by a poly(ADP-ribosyl)ation independent mechanism.
    Lakatos P; Szabó É; Hegedűs C; Haskó G; Gergely P; Bai P; Virág L
    Biochim Biophys Acta; 2013 Mar; 1833(3):743-51. PubMed ID: 23246565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YM155 sensitizes triple-negative breast cancer to membrane-bound TRAIL through p38 MAPK- and CHOP-mediated DR5 upregulation.
    Pennati M; Sbarra S; De Cesare M; Lopergolo A; Locatelli SL; Campi E; Daidone MG; Carlo-Stella C; Gianni AM; Zaffaroni N
    Int J Cancer; 2015 Jan; 136(2):299-309. PubMed ID: 24866585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.
    Woo JS; Kim SM; Jeong CH; Ryu CH; Jeun SS
    Biochem Biophys Res Commun; 2013 Feb; 431(2):354-9. PubMed ID: 23261452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.